T-ALL is an aggressive T-cell malignancy with an inferior treatment outcome compared to B-lineage ALL. Intensive T-ALL research efforts during the last years lead to the identification of multiple genetic abnormalities that cooperate in the malignant transformation of thymocytes. Currently and in contrast to B-lineage ALL, genetic abnormalities are clinically not used for therapy stratification. Further progress on the treatment of T-ALL will require further genetic characterization, which will provide us with a better understanding of the pathogenesis of T-ALL and hopefully will lead to improved treatment schedules. As the general scope of this thesis, we performed genome-wide copy number analysis using array-CGH for the identification of novel genomic rearrangements in T-ALL that possibly relate to treatment outcome, i.e. prognostic factors, or provide further insight in the pathogenesis of T-cell leukemia.

, ,
Pieters, Prof. Dr. R. (promotor), Sophia Foundation for Medical Research (SSWO grant 404)
R. Pieters (Rob)
Erasmus University Rotterdam
Erasmus MC: University Medical Center Rotterdam

van Vlierberghe, P. (2008, April 17). Molecular-genetic insights in pediatric T-cell acute lymphoblastic leukemia. Retrieved from http://hdl.handle.net/1765/12225